A feasibility on Acute Pancreatitis for a global clinical trial was successfully conducted on Credevo with interesting responses from Investigators/Sites.
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Compare the Efficacy and Safety of Ulinastatin versus Placebo in Subjects with Moderately Severe or Severe Acute Pancreatitis.
Sites targeted for this feasibility assessment were medical centers and sites located in India, Denmark, Greece, United Kingdom and United States.
Acute pancreatitis is inflammation of the pancreas, usually accompanied by abdominal pain known as pancreatitis pain and elevations of serum pancreatic enzymes. acute pancreatitis may lead to chronic pancreatitis.
The most common causes of acute pancreatitis are gallstones, heavy alcohol use followed by viral, malignancy, metabolic, ischaemia, direct trauma, smoking and certain medications.
Get the Report
Would you like to contact these investigators and assess feasibility with them for your clinical trial?
Please click below to get detailed feasibility report on Acute Pancreatitis in India, Denmark, Greece, United Kingdom and United States.
Share this report
Recommend this report to your friends and colleagues, who would be benefited with this readily available feasibility report.